Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Cannon Backs FSA Supplement Coverage; NNFA Urges Public Involvement

This article was originally published in The Tan Sheet

Executive Summary

Industry should continue to press for coverage of supplements under health savings and flexible spending accounts, Rep. Chris Cannon (R-Utah) said at the National Nutritional Food Association's Natural Products Convention in Las Vegas July 18

You may also be interested in...



Lane Lawyers Plan To Challenge FDA Restitution Power Under FD&C Act

Lane Labs-USA plans to appeal a permanent injunction on sales of supplements marketed as cancer therapies handed down by a New Jersey federal court, according to Lane attorney Mark Ullman of New York-based Ullman, Shapiro and Ullman

Lane Lawyers Plan To Challenge FDA Restitution Power Under FD&C Act

Lane Labs-USA plans to appeal a permanent injunction on sales of supplements marketed as cancer therapies handed down by a New Jersey federal court, according to Lane attorney Mark Ullman of New York-based Ullman, Shapiro and Ullman

Lane Lawyers Plan To Challenge FDA Restitution Power Under FD&C Act

Lane Labs-USA plans to appeal a permanent injunction on sales of supplements marketed as cancer therapies handed down by a New Jersey federal court, according to Lane attorney Mark Ullman of New York-based Ullman, Shapiro and Ullman

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS097084

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel